Cargando…
Secukinumab in Erythrodermic Psoriasis: Real World Experience of 6 Patients Successfully Treated by Injecting at Unconventional Sites
Biologics which are given subcutaneously are usually injected at certain prementioned sites such as the upper arms, thighs, or any quadrant of the abdomen. In erythrodermic patients, these conventional sites are usually affected. In our series of six patients of psoriatic erythroderma, we selected u...
Autores principales: | Panda, Maitreyee, Raj, Chinmoy, Panda, Anil K, Debata, Ipsita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906320/ https://www.ncbi.nlm.nih.gov/pubmed/35283534 http://dx.doi.org/10.4103/ijd.ijd_221_21 |
Ejemplares similares
-
Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report
por: Carriero, Martino
Publicado: (2022) -
Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report
por: Lu, Xujun, et al.
Publicado: (2023) -
De-novo Histoid Leprosy Masquerading as Lupus Miliaris Disseminatus Faciei: A Unique Presentation
por: Panda, Anil K., et al.
Publicado: (2022) -
Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report
por: Lu, Jiajing, et al.
Publicado: (2020) -
Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab
por: Tichy, Martin
Publicado: (2019)